Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna S Enke

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The British Journal of Radiology|June 28, 2025
New Approaches in Nuclear Medicine TheranosticsJohanna S Enke, Lisa Fenzl, Constantin Lapa, et al.
PET Clinics|July 5, 2024
New PET Tracers for LymphomaJohanna S Enke, Ralph A Bundschuh, Rainer Claus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2023
Sarcoidosis mimicking nodal manifestations of marginal zone lymphomaJohanna S Enke, Nic G Reitsam, Tina Schaller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 15, 2023
Somatostatin Receptor Antagonists as a Theranostic Option in Iodine-Refractory Thyroid CarcinomaJohanna S Enke, Ralph A Bundschuh, Georgine Wienand, et al.
BMC Cancer|January 12, 2024
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancerJohanna S Enke, Matthias Groß, Bianca Grosser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2023
Granulomatous dermatitis: a rare pitfall in lymphoma staging with [<sup>18</sup>F]FDG-PET/CTJohanna S Enke, Alexander Gäble, Nic G Reitsam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2026
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapySong Xue, Sabrina Kraus, Johanna S Enke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2024
Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemiaAlexander Gäble, Johanna S Enke, Martin J Hügle, et al.
American Journal of Respiratory and Critical Care Medicine|October 4, 2023
SSTR Antagonists as Theranostic Option in Small Cell Lung CancerAlessandro Liebich, Johanna S Enke, Nic G Reitsam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [<sup>68</sup>Ga]Ga-LNTH-1363S on Image QualityJohanna S Enke, Jan Baessler, Gitasha Chand, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The British Journal of Radiology|June 28, 2025
New Approaches in Nuclear Medicine TheranosticsJohanna S Enke, Lisa Fenzl, Constantin Lapa, et al.
PET Clinics|July 5, 2024
New PET Tracers for LymphomaJohanna S Enke, Ralph A Bundschuh, Rainer Claus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2023
Sarcoidosis mimicking nodal manifestations of marginal zone lymphomaJohanna S Enke, Nic G Reitsam, Tina Schaller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 15, 2023
Somatostatin Receptor Antagonists as a Theranostic Option in Iodine-Refractory Thyroid CarcinomaJohanna S Enke, Ralph A Bundschuh, Georgine Wienand, et al.
BMC Cancer|January 12, 2024
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancerJohanna S Enke, Matthias Groß, Bianca Grosser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2023
Granulomatous dermatitis: a rare pitfall in lymphoma staging with [<sup>18</sup>F]FDG-PET/CTJohanna S Enke, Alexander Gäble, Nic G Reitsam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2026
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapySong Xue, Sabrina Kraus, Johanna S Enke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2024
Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemiaAlexander Gäble, Johanna S Enke, Martin J Hügle, et al.
American Journal of Respiratory and Critical Care Medicine|October 4, 2023
SSTR Antagonists as Theranostic Option in Small Cell Lung CancerAlessandro Liebich, Johanna S Enke, Nic G Reitsam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [<sup>68</sup>Ga]Ga-LNTH-1363S on Image QualityJohanna S Enke, Jan Baessler, Gitasha Chand, et al.
Pageof 3